Antipsychotic drugs as a contributing factor of pulmonary embolism: A report of 4 cases

• Published in: Radiology Case Reports
• Main Authors: Mosaab Maazouzi, MD, Adnane Bouallala, MD, Zakaria Haddadi, MD, Imane Skiker, PhD, Zakaria bazid, PhD, Nabila ismaili, PhD, Noha El ouafi, PhD
• Format: Article
• Language: English
• Published: Elsevier 2023-05-01
• Subjects: Pulmonary embolism; Antipsychotic drugs; Olanzapine
• Online Access: http://www.sciencedirect.com/science/article/pii/S1930043323001498

Pulmonary embolism is the third leading cause of cardiovascular death in the world after stroke and heart attack; several factors have been identified, and it has been reported that antipsychotic drugs increase the risk of pulmonary embolism. It is a brief communication reporting the case of 4 patients under antipsychotic drugs, were hospitalized in the intensive care unit of cardiology in Mohammed VI hospital center for the management of pulmonary embolism. All the etiological investigations performed including SARS COV2 viral serologies with PCR, tumor markers, chest-abdomen-pelvis CT angiogram scan, phthisiology, thrombophilia tests, and lower limbs echo Doppler returned without any notable findings, and the evolution was positive after anticoagulation and stopping antipsychotics.